84. サルコイドーシス Sarcoidosis Clinical trials / Disease details

臨床試験数 : 149 / 薬物数 : 202 - (DrugBank : 78) / 標的遺伝子数 : 66 - 標的パスウェイ数 : 169

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05247554 (ClinicalTrials.gov)	March 1, 2022	9/2/2022	Randomized Controlled Trial of HydroxychloroquineCombined With Low-dose Corticosteroid in Pulmonary ...	Randomized Controlled Trial Testing the Effect of HydroxychloroquineCombined With Low-dose Corticost ...	Pulmonary Sarcoidosis	Drug: Hydroxychloroquine + low-dose prednisone;Drug: Prednisone	Assistance Publique - Hôpitaux de Paris	NULL	Not yet recruiting	18 Years	80 Years	All	200	Phase 3	NULL
2	NCT02200146 (ClinicalTrials.gov)	March 2009	10/7/2014	Hydroxychloroquine as Steroid-Sparing Agent in Pulmonary Sarcoidosis (HySSAS).	Hydroxychloroquineas Steroid-Sparing Agent in Pulmonary Sarcoidosis (HySSAS). A Multicenter, Prospec ...	Pulmonary Sarcoidosis	Drug: Prednisone;Drug: Hydroxychloroquine + Prednisone	University of Milano Bicocca	Agenzia Italiana del Farmaco	Completed	18 Years	70 Years	Both	94	Phase 3	Italy
3	EUCTR2008-001340-39-IT (EUCTR)	30/06/2008	13/06/2008	Hydroxychloroquineas Steroid-Sparing Agent in pulmonary Sarcoidosis (HySSAS). A multicenter, prospec ...	Hydroxychloroquineas Steroid-Sparing Agent in pulmonary Sarcoidosis (HySSAS). A multicenter, prospec ...	Pulmonary Sarcoidosis	Trade Name: PLAQUENIL*25CPR RIV 200MG INN or Proposed INN: Hydroxychloroquine Trade Name: DELTACORTENE ...	UNIVERSITA' DEGLI STUDI DI MILANO-BICOCCA	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes			Italy

First Previous1Next Last